Literature DB >> 21285444

Sensitivity and specificity of subacute computerized neurocognitive testing and symptom evaluation in predicting outcomes after sports-related concussion.

Brian C Lau1, Michael W Collins, Mark R Lovell.   

Abstract

BACKGROUND: Concussions affect an estimated 136 000 high school athletes yearly. Computerized neurocognitive testing has been shown to be appropriately sensitive and specific in diagnosing concussions, but no studies have assessed its utility to predict length of recovery. Determining prognosis during subacute recovery after sports concussion will help clinicians more confidently address return-to-play and academic decisions.
PURPOSE: To quantify the prognostic ability of computerized neurocognitive testing in combination with symptoms during the subacute recovery phase from sports-related concussion. STUDY
DESIGN: Cohort study (prognosis); Level of evidence, 2.
METHODS: In sum, 108 male high school football athletes completed a computer-based neurocognitive test battery within 2.23 days of injury and were followed until returned to play as set by international guidelines. Athletes were grouped into protracted recovery (>14 days; n = 50) or short-recovery (≤14 days; n = 58). Separate discriminant function analyses were performed using total symptom score on Post-Concussion Symptom Scale, symptom clusters (migraine, cognitive, sleep, neuropsychiatric), and Immediate Postconcussion Assessment and Cognitive Testing neurocognitive scores (verbal memory, visual memory, reaction time, processing speed).
RESULTS: Multiple discriminant function analyses revealed that the combination of 4 symptom clusters and 4 neurocognitive composite scores had the highest sensitivity (65.22%), specificity (80.36%), positive predictive value (73.17%), and negative predictive value (73.80%) in predicting protracted recovery. Discriminant function analyses of total symptoms on the Post-Concussion Symptom Scale alone had a sensitivity of 40.81%; specificity, 79.31%; positive predictive value, 62.50%; and negative predictive value, 61.33%. The 4 symptom clusters alone discriminant function analyses had a sensitivity of 46.94%; specificity, 77.20%; positive predictive value, 63.90%; and negative predictive value, 62.86%. Discriminant function analyses of the 4 computerized neurocognitive scores alone had a sensitivity of 53.20%; specificity, 75.44%; positive predictive value, 64.10%; and negative predictive value, 66.15%.
CONCLUSION: The use of computerized neurocognitive testing in conjunction with symptom clusters results improves sensitivity, specificity, positive predictive value, and negative predictive value of predicting protracted recovery compared with each used alone. There is also a net increase in sensitivity of 24.41% when using neurocognitive testing and symptom clusters together compared with using total symptoms on Post-Concussion Symptom Scale alone.

Entities:  

Mesh:

Year:  2011        PMID: 21285444     DOI: 10.1177/0363546510392016

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  42 in total

Review 1.  The management of sport-related concussion: considerations for male and female athletes.

Authors:  Tracey Covassin; R J Elbin; Bryan Crutcher; Scott Burkhart
Journal:  Transl Stroke Res       Date:  2012-12-06       Impact factor: 6.829

Review 2.  Administration and environment considerations in computer-based sports-concussion assessment.

Authors:  Annalise A M Rahman-Filipiak; John L Woodard
Journal:  Neuropsychol Rev       Date:  2013-12-04       Impact factor: 7.444

Review 3.  Assessment, management and knowledge of sport-related concussion: systematic review.

Authors:  Doug King; Matt Brughelli; Patria Hume; Conor Gissane
Journal:  Sports Med       Date:  2014-04       Impact factor: 11.136

Review 4.  Expert consensus document: Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions.

Authors:  Aaron J Carman; Rennie Ferguson; Robert Cantu; R Dawn Comstock; Penny A Dacks; Steven T DeKosky; Sam Gandy; James Gilbert; Chad Gilliland; Gerard Gioia; Christopher Giza; Michael Greicius; Brian Hainline; Ronald L Hayes; James Hendrix; Barry Jordan; James Kovach; Rachel F Lane; Rebekah Mannix; Thomas Murray; Tad Seifert; Diana W Shineman; Eric Warren; Elisabeth Wilde; Huntington Willard; Howard M Fillit
Journal:  Nat Rev Neurol       Date:  2015-03-17       Impact factor: 42.937

5.  Estimated Age of First Exposure to American Football and Neurocognitive Performance Amongst NCAA Male Student-Athletes: A Cohort Study.

Authors:  Jaclyn B Caccese; Ryan M DeWolf; Thomas W Kaminski; Steven P Broglio; Thomas W McAllister; Michael McCrea; Thomas A Buckley
Journal:  Sports Med       Date:  2019-03       Impact factor: 11.136

6.  Residual brain dysfunction observed one year post-mild traumatic brain injury: combined EEG and balance study.

Authors:  Semyon Slobounov; Wayne Sebastianelli; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2012-02-22       Impact factor: 3.708

Review 7.  The young brain and concussion: imaging as a biomarker for diagnosis and prognosis.

Authors:  Esteban Toledo; Alyssa Lebel; Lino Becerra; Anna Minster; Clas Linnman; Nasim Maleki; David W Dodick; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2012-03-28       Impact factor: 8.989

Review 8.  Validity of the Immediate Post Concussion Assessment and Cognitive Testing (ImPACT).

Authors:  Bara Alsalaheen; Kayla Stockdale; Dana Pechumer; Steven P Broglio
Journal:  Sports Med       Date:  2016-10       Impact factor: 11.136

9.  Chiropractic Management of Musculoskeletal Symptoms in a 14-Year-Old Hockey Player With Postconcussion Symptoms: A Case Report.

Authors:  Harold M Olson; Michael J Tunning; Ronnie J Boesch
Journal:  J Chiropr Med       Date:  2016-05-27

10.  Comparison of the balance accelerometer measure and balance error scoring system in adolescent concussions in sports.

Authors:  Gabriel R Furman; Chia-Cheng Lin; Jennica L Bellanca; Gregory F Marchetti; Michael W Collins; Susan L Whitney
Journal:  Am J Sports Med       Date:  2013-04-12       Impact factor: 6.202

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.